1. Bellando-Randone S, Matucci-Cerinic M. Very early systemic sclerosis and pre-systemic sclerosis: definition, recognition, clinical relevance and future directions. Curr Rheumatol Rep. 2017;19:65.
2. Nasr AS, Fawzy SM, Gheita TA, El-Khateeb E. Expression of Toll-like receptors 3 and 9 in Egyptian systemic lupus erythematosus patients. Z Rheumatol. 2016;75:502-7.
3. Chen K, See A, Shumack S. Epidemiology and pathogenesis of scleroderma. Aust J Dermatol. 2003;44:1-7; quiz 8-9.
4. Takeda K, Akira S. Toll-like receptors. Curr Protoc Immunol. 2015;109:14.12.1-10.
5. Celhar T, Fairhurst AM. Toll-like receptors in systemic lupus erythematosus: potential for personalized treatment. Front Pharmacol. 2014;5:265.
6. Wu YW, Tang W, Zuo JP: Toll-like receptors: potential targets for lupus treatment. Acta Pharmacol Sin 2015, 36(12):1395-1407.
7. Nakou M, Papadimitraki ED, Fanouriakis A, Bertsias GK, Choulaki C, Goulidaki N, et al. Interleukin-21 is increased in active systemic lupus erythematosus patients and contributes to the generation of plasma B cells. Clin Exp Rheumatol. 2013;31:172-9.
7. Ma K, Li J, Wang X, Lin X, Du W, Yang X, et al. TLR4+CXCR4+ plasma cells drive nephritis development in systemic lupus erythematosus. Ann Rheum Dis. 2018;77:1498-506.
8. O'Reilly S. Toll like receptors in systemic sclerosis: an emerging target. Immunol Lett. 2018;195:2-8.
9. Yang J, An J-X, Liu X-L, Wang Z-Q, Xie G-M, Yang X-L, et al. Next generation sequencing identified a novel multi exon deletion of the NF1 gene in a Chinese pedigree with neurofibromatosis type 1. Balkan J Med Genet. 2018;21:45-8.
10. Bhattacharyya S, Varga J: Emerging roles of innate immune signaling and toll-like receptors in fibrosis and systemic sclerosis. Current rheumatology reports 2015, 17(1):474.
11. Petrackova A, Horak P, Radvansky M, Skacelova M, Fillerova R, Kudelka M, Smrzova A, Mrazek F, Kriegova E: Cross-Disease Innate Gene Signature: Emerging Diversity and Abundance in RA Comparing to SLE and SSc. J Immunol Res 2019, 2019:3575803.
12. Aken BL, Ayling S, Barrell D, Clarke L, Curwen V, Fairley S, et al. The Ensembl gene annotation system. Database (Oxford). 2016;2016:baw093.
13. Adigun R, Bhimji SS: Systemic Sclerosis (CREST syndrome). In: StatPearls. Treasure Island (FL): StatPearls Publishing LLC.; 2018.
14. Pickard MAG, Brylow KB, Cisco LA, Anecelle MR, Pershun ML, Chandrasekaran AR, Halvorsen K, Gleghorn ML: Parallel poly(A) homo- and hetero-duplex formation detection with an adapted DNA nanoswitch technique. Rna 2020, 26(9):1118-1130.
15. Mwangi C, Njoroge S, Tshibangu-Kabamba E, Moloo Z, Rajula A, Devani S, Matsumoto T, Nyerere K, Kariuki S, Revathi G et al: Whole Genome Sequencing Reveals Virulence Potentials of Helicobacter pylori Strain KE21 Isolated from a Kenyan Patient with Gastric Signet Ring Cell Carcinoma. Toxins (Basel) 2020, 12(9).
16. Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15-21.
17. Anders S, Pyl PT, Huber W. HTSeq—a Python framework to work with high-throughput sequencing data. Bioinformatics. 2015;31:166-9.
18. Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.
19. Luo W, Brouwer C. Pathview: an R/Bioconductor package for pathway-based data integration and visualization. Bioinformatics. 2013;29:1830-1.
20. Luo W, Friedman MS, Shedden K, Hankenson KD, Woolf PJ. GAGE: generally applicable gene set enrichment for pathway analysis. BMC Bioinformatics. 2009;10:161.
21. Ignatiadis N, Klaus B, Zaugg JB, Huber W. Data-driven hypothesis weighting increases detection power in genome-scale multiple testing. Nat Meth. 2016;13:577-80.
22. Viganò M, Perucca Orfei C, de Girolamo L, Pearson JR, Ragni E, De Luca P, et al. Housekeeping gene stability in human mesenchymal stem and tendon cells exposed to tenogenic factors. Tissue Eng Part C Methods. 2018;24:360-7.
23. Luo X, Li J, Chang T, He H, Zhao Y, Yang X, Zhao Y, Xu Y: Stable Reference Gene Selection for RT-qPCR Analysis in Synechococcus elongatus PCC 7942 under Abiotic Stresses. Biomed Res Int 2019, 2019:7630601.
24. Wei K, Ma L: Concept development of housekeeping genes in the high-throughput sequencing era. Yi Chuan 2017, 39(2):127-134.
25. Brown M, O'Reilly S: The immunopathogenesis of fibrosis in systemic sclerosis. Clinical and experimental immunology 2019, 195(3):310-321.
26.Chen JQ, Szodoray P, Zeher M. Toll-like receptor pathways in autoimmune diseases. Clin Rev Allergy Immunol. 2016;50:1-17.
27. Brown M, O'Reilly S. Innate immunity and Toll-like receptor signaling in the pathogenesis of scleroderma: advances and opportunities for therapy. Curr Opin Rheumatol. 2018;30:600-5.
28. Vidya MK, Kumar VG, Sejian V, Bagath M, Krishnan G, Bhatta R. Toll-like receptors: significance, ligands, signaling pathways, and functions in mammals. Int Rev Immunol. 2018;37:20-36.
29. Wang Y, Pan CQ, Xing H. Advances in gut microbiota of viral hepatitis cirrhosis. Biomed Res Int. 2019;2019:9726786.
30. Agarwal SK, Wu M, Livingston CK, Parks DH, Mayes MD, Arnett FC, et al. Toll-like receptor 3 upregulation by type I interferon in healthy and scleroderma dermal fibroblasts. Arthritis Res Ther. 2011;13:R3.
31. Mohammadi Z, Poustchi H, Motamed-Gorji N, Eghtesad S, Hekmatdoost A, Saniee P, et al. Fecal microbiota in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: a systematic review. Arch Iran Med. 2020;23:44-52.
32. Ciechomska M, Cant R, Finnigan J, van Laar JM, O'Reilly S: Role of toll-like receptors in systemic sclerosis. Expert Rev Mol Med 2013, 15:e9.